Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10426)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2021 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, Díaz-Camargo E, Medina O, Rojas-Quintero J, Bermúdez V. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World J Diabetes 2021; 12(6): 745-766 [PMID: 34168725 DOI: 10.4239/wjd.v12.i6.745] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i6/745.htm |
| Number | Citing Articles |
| 1 |
Geetika Nehra, Bjoern Bauer, Anika M.S. Hartz. Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance. Pharmacology & Therapeutics 2022; 234: 108119 doi: 10.1016/j.pharmthera.2022.108119
|
| 2 |
Teresa Vezza, Víctor M Víctor. SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2023; doi: 10.1210/clinem/dgad740
|
| 3 |
Fan Zhang, Melissa Petersen, Leigh Johnson, James Hall, Sid E. O’Bryant. Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer’s Disease in the HABS-HD Study. Journal of Alzheimer's Disease 2023; 96(4): 1529 doi: 10.3233/JAD-230755
|
| 4 |
Ides M Colin, Lidia W Szczepanski, Anne-Catherine Gérard, Jose-Antonio Elosegi. Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s Disease. European Endocrinology 2023; 19(1): 16 doi: 10.17925/EE.2023.19.1.16
|
| 5 |
Keke Song, Rongrong Zhang, Xiaoqi Zhao, Lan Yang, Qiang Wang, Wei Gao. Perioperative neurocognitive disorder changes in elderly diabetes patients within 30 days after surgery: a retrospective cohort study. Aging Clinical and Experimental Research 2023; 35(12): 2911 doi: 10.1007/s40520-023-02583-9
|
| 6 |
Khaled Hameed Husain, Saud Faisal Sarhan, Haya Khaled Ali Abdulla AlKhalifa, Asal Buhasan, Abu Saleh Md Moin, Alexandra E. Butler. Dementia in Diabetes: The Role of Hypoglycemia. International Journal of Molecular Sciences 2023; 24(12): 9846 doi: 10.3390/ijms24129846
|
| 7 |
Tatiana Korolenko, Nina Dubrovina, Marina Ovsyukova, Nataliya Bgatova, Michael Tenditnik, Alexander Pupyshev, Anna Akopyan, Natalya Goncharova, Chih-Li Lin, Evgeny Zavjalov, Maria Tikhonova, Tamara Amstislavskaya. Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db Mice. Cells 2021; 10(10): 2557 doi: 10.3390/cells10102557
|
| 8 |
Haiyang Du, Xiaoyu Meng, Yu Yao, Jun Xu. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1033479
|
| 9 |
Kayalvizhi Rajendran, Uma Maheswari Krishnan. Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease. Ageing Research Reviews 2024; 97: 102309 doi: 10.1016/j.arr.2024.102309
|
| 10 |
Jiwei Jiang, Hanping Shi, Shirui Jiang, Anxin Wang, Xinying Zou, Yanli Wang, Wenyi Li, Yuan Zhang, Mengfan Sun, Qiwei Ren, Jun Xu. Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism. Science China Life Sciences 2023; 66(10): 2257 doi: 10.1007/s11427-022-2276-6
|
| 11 |
Richard Simon Machado, Khiany Mathias, Larissa Joaquim, Rafaella Willig de Quadros, Fabricia Petronilho, Gislaine Tezza Rezin. From diabetic hyperglycemia to cerebrovascular Damage: A narrative review. Brain Research 2023; 1821: 148611 doi: 10.1016/j.brainres.2023.148611
|
| 12 |
Nagwa M. Abdelazeem, Wael M. Aboulthana, Ashraf S. Hassan, Abdulrahman A. Almehizia, Ahmed M. Naglah, Hamad M. Alkahtani. Synthesis, in silico ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents. Saudi Pharmaceutical Journal 2024; 32(5): 102025 doi: 10.1016/j.jsps.2024.102025
|
| 13 |
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, Ana W. Capuano, Han Tong, Vladislav A. Petyuk, Shannon L. Macauley, Xavier Fioramonti, Owen Carmichael, Frederic Calon, Zoe Arvanitakis. State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease. Aging and disease 2023; : 0 doi: 10.14336/AD.2023.0814
|
| 14 |
Hoda M. Moghazy, Nesreen G Abdelhaliem, Sherine Ahmed Mohammed, Asmaa Hassan, Amany Abdelrahman. Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model. Pflügers Archiv - European Journal of Physiology 2024; 476(5): 779 doi: 10.1007/s00424-024-02933-0
|
| 15 |
Toshiyuki Oshitari. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina. International Journal of Molecular Sciences 2023; 24(3): 2927 doi: 10.3390/ijms24032927
|
| 16 |
Xin Yuan, Fei Yan, Li‐Hui Gao, Qian‐Hui Ma, Ju Wang. Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning. CNS Neuroscience & Therapeutics 2023; 29(11): 3307 doi: 10.1111/cns.14260
|
| 17 |
Guglielmina Froldi. View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences. Pharmaceuticals 2024; 17(4): 478 doi: 10.3390/ph17040478
|
| 18 |
Keiko Shigemori, Sachiko Nomura, Tomohiro Umeda, Shuko Takeda, Takami Tomiyama. Peripheral Aβ acts as a negative modulator of insulin secretion. Proceedings of the National Academy of Sciences 2022; 119(12) doi: 10.1073/pnas.2117723119
|
| 19 |
Jessica E.B.F. Lima, Natalia C.S. Moreira, Elza T. Sakamoto-Hojo. Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2022; : 503437 doi: 10.1016/j.mrgentox.2021.503437
|
| 20 |
Renshi Li, Fengjie Zheng, Peichen Xu, Li Lv, Yapeng Mu, Xianghua Zhuang, Shihong Chen. Correlation of mild cognitive impairment with the thickness of retinal nerve fiber layer and serum indicators in type 2 diabetic patients. Frontiers in Endocrinology 2024; 14 doi: 10.3389/fendo.2023.1299206
|
| 21 |
Flavia Agata Cimini, Marzia Perluigi, Ilaria Barchetta, Maria Gisella Cavallo, Eugenio Barone. Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update. International Journal of Molecular Sciences 2022; 23(10): 5574 doi: 10.3390/ijms23105574
|
| 22 |
Sophia Nazir. Salivary biomarkers: The early diagnosis of Alzheimer's disease. AGING MEDICINE 2024; doi: 10.1002/agm2.12282
|
| 23 |
Ting Li, Hong-xia Cao, Dan Ke. Type 2 Diabetes Mellitus Easily Develops into Alzheimer’s Disease via Hyperglycemia and Insulin Resistance. Current Medical Science 2021; 41(6): 1165 doi: 10.1007/s11596-021-2467-2
|
| 24 |
Laryssa Alves-Borba, Verónica Espinosa-Fernández, Ania Canseco-Rodríguez, Ana María Sánchez-Pérez. ABA Supplementation Rescues IRS2 and BDNF mRNA Levels in a Triple-Transgenic Mice Model of Alzheimer’s Disease. Journal of Alzheimer's Disease Reports 2023; 7(1): 1007 doi: 10.3233/ADR-230056
|
| 25 |
Yashika Arora, Anirban Dutta. Perspective: Disentangling the effects of tES on neurovascular unit. Frontiers in Neurology 2023; 13 doi: 10.3389/fneur.2022.1038700
|
| 26 |
Norhamidar Ab-Hamid, Norsuhana Omar, Che Aishah Nazariah Ismail, Idris Long. Diabetes and cognitive decline: Challenges and future direction. World Journal of Diabetes 2023; 14(6): 795-807 doi: 10.4239/wjd.v14.i6.795
Abstract(491) |
Core Tip(182) |
Full Article(HTML)(1241)
|
Full Article with Cover (PDF)-1108K(32)
|
Full Article (Word)-469K(20)
|
Audio-295K(0)
|
Peer-Review Report-216K(22)
|
Answering Reviewers-109K(21)
|
Full Article (PDF)-902K(128)
|
Full Article (XML)-171K(26)
|
Times Cited (6)
|
Total Visits (2978)
|
Open
|
| 27 |
Jiehui Chen, Yong Liu, Keru Zhou, Wei Zhang, Bin Wen, Kai Xu, Yazhou Liu, Ling Chen, Yue Huang, Benhong He, Weijian Hang, Juan Chen. DISC1 inhibits GSK3β activity to prevent tau hyperphosphorylation under diabetic encephalopathy. BioFactors 2023; 49(1): 173 doi: 10.1002/biof.1884
|
| 28 |
Ozra Tabatabaei Malazy, Fatemeh Bandarian, Mostafa Qorbani, Shahrzad Mohseni, Somayeh Mirsadeghi, Maryam Peimani, Bagher Larijani. The effect of metformin on cognitive function: A systematic review and meta-analysis. Journal of Psychopharmacology 2022; 36(6): 666 doi: 10.1177/02698811211057304
|
| 29 |
Zheng Shen, Zheng-Yang Li, Meng-Ting Yu, Kai-Leng Tan, Si Chen. Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains. Biomedicine & Pharmacotherapy 2023; 158: 114206 doi: 10.1016/j.biopha.2022.114206
|
| 30 |
Yanchun Li, Zhongyang Lu, Cameron L. Kirkwood, Keith L. Kirkwood, Stephen A. Wank, Ai‐Jun Li, Maria F. Lopes‐Virella, Yan Huang. GPR40 deficiency worsens metabolic syndrome‐associated periodontitis in mice. Journal of Periodontal Research 2023; 58(3): 575 doi: 10.1111/jre.13107
|
| 31 |
Xian-wen Ye, Meng-nan Liu, Xuan Wang, Shui-qing Cheng, Chun-shuai Li, Yu-ying Bai, Lin-lin Yang, Xu-xing Wang, Jia Wen, Wen-juan Xu, Shu-yan Zhang, Xin-fang Xu, Xiang-ri Li. Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysis. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1071391
|